# Clinical Pharmacology Study of MP-424

> **NCT01766167** · PHASE1 · COMPLETED · sponsor: **Tanabe Pharma Corporation** · enrollment: 26 (actual)

## Conditions studied

- Chronic Hepatitis C

## Interventions

- **DRUG:** MP-424
- **DRUG:** MP-424
- **DRUG:** MP-424
- **DRUG:** MP-424

## Key facts

- **NCT ID:** NCT01766167
- **Lead sponsor:** Tanabe Pharma Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-02
- **Primary completion:** 2013-04
- **Final completion:** 2013-04
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2017-01-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01766167

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01766167, "Clinical Pharmacology Study of MP-424". Retrieved via AI Analytics 2026-06-06 from https://api.ai-analytics.org/clinical/NCT01766167. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*